Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex

The prefrontal cortex has often been implicated in the pathophysiology of schizophrenia. Schizophrenic patients are known to suffer from certain information processing deficits, which can be detected, among others, in the prepulse inhibition and the latent inhibition paradigm. The present study was designed to investigate the role of dopamine receptors in the medial prefrontal cortex in prepulse inhibition and latent inhibition. The results show that the local application of the selective antagonist of the dopamine D1-like receptor family, SCH 39166, into the medial prefrontal cortex dose-dependently reduced prepulse inhibition. Likewise, the selective antagonist of the dopamine D2-like receptor family, sulpiride, injected into the medial prefrontal cortex dose-dependently reduced prepulse inhibition. Neither of these antagonists, however, influenced latent inhibition as measured with the conditioned taste aversion paradigm. These data further indicate that the neuronal substrates of latent inhibition and prepulse inhibition are clearly different. Since the prefrontal cortex is intimately related to subcortical dopamine, the possible differential involvement of subcortical dopaminergic terminal fields in prepulse inhibition and latent inhibition is discussed.

[1]  J. Tassin NE/DA interactions in prefrontal cortex and their possible roles as neuromodulators in schizophrenia. , 1992, Journal of neural transmission. Supplementum.

[2]  B. Bogerts,et al.  The neuropathology of schizophrenia: past and present. , 1993, Journal fur Hirnforschung.

[3]  A. Cools,et al.  Animal models with construct validity for schizophrenia. , 1990, Behavioural pharmacology.

[4]  M. Koch,et al.  Deficient Sensorimotor Gating After 6‐Hydroxydopamine Lesion of the Rat medial Prefrontal Cortex is Reversed by Haloperidol , 1994, The European journal of neuroscience.

[5]  Christian Grillon,et al.  Gating and habituation of the startle reflex in schizophrenic patients. , 1992 .

[6]  J. Bruno,et al.  Effects of haloperidol and SCH 23390 on acoustic startle and prepulse inhibition under basal and stimulated conditions , 1993, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[7]  T. Crow,et al.  The neuropathology of schizophrenia--a progress report. , 1987, British medical bulletin.

[8]  Daniel R. Weinberger,et al.  Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground , 1995, Schizophrenia Research.

[9]  J. Gray,et al.  Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET , 1995, Schizophrenia Research.

[10]  F Plum,et al.  Prospects for research on schizophrenia. 3. Neurophysiology. Neuropathological findings. , 1972, Neurosciences Research Program bulletin.

[11]  M. Le Moal,et al.  Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltammetric study , 1989, Neuroscience.

[12]  A. Gratton,et al.  Partial dopamine depletion of the prefrontal cortex leads to enhanced mesolimbic dopamine release elicited by repeated exposure to naturally reinforcing stimuli , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  B. Pakkenberg,et al.  Post-mortem Study of Chronic Schizophrenic Brains , 1987, British Journal of Psychiatry.

[14]  C. J. Schmidt,et al.  The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. , 1995, European journal of pharmacology.

[15]  R. Lubow Latent Inhibition and Conditioned Attention Theory , 1989 .

[16]  T. Crow,et al.  Schizophrenia and the brain: a prospective clinico-neuropathological study , 1990, Psychological Medicine.

[17]  D. Weinberger,et al.  Relationship between CT scan findings and neuropsychological performance in chronic schizophrenia. , 1986, The Psychiatric clinics of North America.

[18]  Stanley J. Watson,et al.  The rat brain in stereotaxic coordinates (2nd edn) by George Paxinos and Charles Watson, Academic Press, 1986. £40.00/$80.00 (264 pages) ISBN 012 547 6213 , 1987, Trends in Neurosciences.

[19]  Ariel Y. Deutch,et al.  Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress , 1990, Brain Research.

[20]  J. Ehrhardt,et al.  Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities. , 1990, Archives of general psychiatry.

[21]  J. Lowinson,et al.  Presynaptic dopamine release is enhanced by 5‐HT3 receptor activation in medial prefrontal cortex of freely moving rats , 1992, Synapse.

[22]  M. Zigmond,et al.  Local Influence of Endogenous Norepinephrine on Extracellular Dopamine in Rat Medial Prefrontal Cortex , 1995, Journal of neurochemistry.

[23]  Christensen Av Classification of neuroleptics: implications for tardive dyskinesia. , 1985 .

[24]  A. Cools,et al.  The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm , 1997, Psychopharmacology.

[25]  J. Glowinski,et al.  Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D‐1 Dopamine Receptor , 1991, The European journal of neuroscience.

[26]  A. Cools,et al.  Maternal Separation Reduces Latent Inhibition in the Conditioned Taste-Aversion Paradigm , 1995 .

[27]  J. Gray,et al.  Differential Performance of Acute and Chronic Schizophrenics in a Latent Inhibition Task , 1988, The Journal of nervous and mental disease.

[28]  N. Swerdlow,et al.  Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics , 1986, Biological Psychiatry.

[29]  G. Chiara,et al.  Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic Terminals , 1990, Journal of neurochemistry.

[30]  R. Mcquade,et al.  [3H]SCH 39166, A New D1‐Selective Radioligand: In Vitro and In Vivo Binding Analyses , 1991, Journal of neurochemistry.

[31]  B. Ellenbroek,et al.  The behavior of APO-SUS rats in animal models with construct validity for schizophrenia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.